Bozena Szymanska
Overview
Explore the profile of Bozena Szymanska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wlodarski A, Szymczak-Pajor I, Kasznicki J, Antanaviciute E, Szymanska B, Sliwinska A
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791447
The escalating prevalence of carbohydrate metabolism disorders (CMDs) prompts the need for early diagnosis and effective markers for their prediction. Hyperglycemia, the primary indicator of CMDs including prediabetes and type...
2.
Szubert M, Nowak-Gluck A, Domanska-Senderowska D, Szymanska B, Sowa P, Rycerz A, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139300
Endometriosis-associated ovarian cancer (EOC) consisting of endometrioid cancer and clear-cell ovarian cancer could be promoted by many factors. miRNAs, which are small, non-coding molecules of RNA, are among them. The...
3.
Slowinska-Klencka D, Popowicz B, Kulczycka-Wojdala D, Szymanska B, Duda-Szymanska J, Wojtaszek-Nowicka M, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686562
The aim of the study was to analyze the diagnostic usefulness of the combined assessment of the ultrasound risk category of the nodule (evaluated with EU-TIRADS system), the presence of...
4.
Boguszewska-Byczkiewicz K, Wow T, Szymanska B, Kosny M, Kolacinska-Wow A
Mol Biol Rep
. 2023 May;
50(7):6279-6285.
PMID: 37212960
Introduction: The aim of the study is to determine the relationship between polymorphisms rs11568821 C/T and at rs2227981 G/A in the programmed cell death 1 gene (PDCD1) and the clinicopathologic...
5.
Nowicki M, Wierzbowska A, Szymanska B, Nowicki G, Szmigielska-Kaplon A
Exp Hematol
. 2023 Mar;
122:30-40.e1.
PMID: 36906219
Mobilization of CD34+ cells is a key element in the therapy of patients with multiple myeloma (MM) undergoing autologous stem cell transplantation. The use of chemotherapy and the granulocyte colony-stimulating...
6.
Szubert M, Nowak-Gluck A, Domanska-Senderowska D, Szymanska B, Sowa P, Rycerz A, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563053
Micro-RNAs expression can vary between different forms of endometriosis, but data on miRNA expression in cesarean scar endometriosis is lacking. The present study is comprised of 30 patients with endometriosis...
7.
Bienkiewicz J, Romanowicz H, Szymanska B, Domanska-Senderowska D, Wilczynski M, Stepowicz A, et al.
BMC Cancer
. 2022 Mar;
22(1):343.
PMID: 35351056
Background: The analysis of long non-coding RNA (lncRNA) in endometrial cancer is a novel field of science. Although numerous lncRNA sequences have been identified until today, their correlation with endometrial...
8.
Berent D, Szymanska B, Kulczycka-Wojdala D, Macander M, Pawlowska Z, Wojnar M
Pharmacol Rep
. 2021 Jun;
73(5):1482.
PMID: 34155598
No abstract available.
9.
Rechcinski T, Szymanska B, Wierzbowska-Drabik K, Chmiela M, Matusiak A, Kurpesa M, et al.
J Clin Med
. 2021 Apr;
10(5).
PMID: 33801199
Background And Objectives: Some experimental studies demonstrated adverse modulation of atherothrombosis by interleukin-1beta (IL-1b). To assess the relationship between the five most common variants of three polymorphisms of the IL1b...
10.
Wilczynski M, Kielbik M, Senderowska D, Krawczyk T, Szymanska B, Klink M, et al.
Cancers (Basel)
. 2020 Sep;
12(9).
PMID: 32961797
High levels of miRNA-103/107 are associated with poor outcomes in the case of breast cancer patients. MiRNA-103/107-DICER axis may be one of the key regulators of cancer aggressiveness. MiRNA-103/107 expression...